From first samuels website -
Indiore advised that it has insufficient ore to process through its Phase 3 process plant. The company has cancelled the Phase 3 project, and initiated an independent review of the Phase 3 project’s approval and go-ahead process. This is a very disappointing development. The company is in a trading halt until 28-Feb-19, with a further announcement expected then.
We will monitor the outcome of the independent review, and review the company’s proposed way forward, before making any decisions regarding this investment.
Indiore was a smaller weight in your equity portfolio. (Such investments are often progressed in a measured way – with an initial portfolio weight usually not exceeding 3% - then exposure increased as the company develops and grows.) Even as a smaller weight, this is still a disappointing and unexpected outcome
- Forums
- ASX - By Stock
- ELE
- Ann: Extension of voluntary suspension
Ann: Extension of voluntary suspension, page-8
Featured News
Add ELE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online